A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors

Clinical trial NCT02955251 · COMPLETED

Trial details

NCT number: NCT02955251
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Cancer

Start date: 2016-11-18
Primary completion: 2019-10-29
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.